Perin P V, Weldon D, McGeady S J
Thomas Jefferson University, Division of Allergy and Clinical Immunology, Philadelphia, PA 19107-5541.
J Allergy Clin Immunol. 1994 Sep;94(3 Pt 1):517-22. doi: 10.1016/0091-6749(94)90208-9.
Subjects with asthma who are intensively treated in residential care facilities frequently demonstrate marked clinical improvement in their disease, with fewer attacks and improved well being. Despite their improved status, it is known that pulmonary function test results often remain abnormal in patients with asthma. This prospective study on children with asthma receiving residential care was carried out to determine which pulmonary function parameter best reflected clinical improvement through correlation with the duration of complete freedom from wheezing. Evaluated in 42 children were spirometry values including forced vital capacity, forced expiratory volume in 1 second, peak expiratory flow rate, forced expiratory flow (between 25% and 75% of forced vital capacity), and lung volumes as reflected by residual volume/total lung capacity. Bronchial hyperreactivity as reflected by bimonthly provocative concentration causing a 20% fall in FEV1 in response to methacholine inhalation was evaluated in 18 patients. All pulmonary function test results were correlated with days since last wheezing episode. Results indicate that only peak expiratory flow rate (r = 0.91; p < 0.001), forced expiratory volume in 1 second (r = 0.69; p < 0.01), and forced expiratory flow (r = 0.62; p < 0.05) demonstrated significant correlation with the number of days since last wheezing episode. Of particular interest was the failure of bronchial hyperreactivity to improve despite intensive therapy with bronchodilators and corticosteroids. Persistence of bronchial hyperreactivity despite intensive therapy with corticosteroids suggests that in at least some children with severe asthma, bronchial hyperreactivity may be especially long-lived, may be perpetuated by inhaled beta 2 agonists, or may exist independently of airway inflammation.
在寄宿护理机构接受强化治疗的哮喘患者,其病情常显示出显著的临床改善,发作次数减少,健康状况改善。尽管他们的病情有所改善,但已知哮喘患者的肺功能测试结果往往仍不正常。这项针对接受寄宿护理的哮喘儿童的前瞻性研究旨在确定哪种肺功能参数通过与完全无喘息持续时间的相关性,能最好地反映临床改善情况。对42名儿童进行了肺活量测定值评估,包括用力肺活量、1秒用力呼气量、呼气峰值流速、用力呼气流量(用力肺活量的25%至75%之间)以及由残气量/肺总量反映的肺容积。对18名患者评估了通过吸入乙酰甲胆碱引起FEV1下降20%的双月激发浓度所反映的支气管高反应性。所有肺功能测试结果均与上次喘息发作后的天数相关。结果表明,只有呼气峰值流速(r = 0.91;p < 0.001)、1秒用力呼气量(r = 0.69;p < 0.01)和用力呼气流量(r = 0.62;p < 0.05)与上次喘息发作后的天数显示出显著相关性。特别值得关注的是,尽管使用支气管扩张剂和皮质类固醇进行强化治疗,支气管高反应性仍未改善。尽管使用皮质类固醇进行强化治疗,支气管高反应性仍然持续存在,这表明至少在一些重度哮喘儿童中,支气管高反应性可能持续时间特别长,可能由吸入的β2激动剂维持,或者可能独立于气道炎症而存在。